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Summary 
It has been shown that many solid malignancies, including oral squamous cell 
carcinoma (OSCC), contain a small population of tumorigenic cells referred to as 
cancer stem-like cells (CSCs) or tumor initiating cells (TICs). The concept of stem 
cell hierarchy in cancers, coupled to the phenomenon of epithelial-to-mesenchymal 
transition (EMT), seems to explain well the biology of most cancers, as well as the 
failure of the currently used therapeutical methods. Nevertheless, more evidence is 
needed for understanding of both these concepts as well as the relationship between 
them in cancer in general, and in OSCC in particular.  
By using marker-based fluorescence-activated cell sorting (FACS), the most 
commonly used method for isolation of CSCs, we aimed to investigate whether there 
is a link between CSCs and the EMT phenomenon in OSCC-derived cell lines and 
primary cells (Paper I). Subpopulations of cells were sorted by FACS using their 
differential expression of the CD44 adhesion molecule and epithelial specific antigen 
(ESA), and then investigated for stem cell and EMT properties both in vitro and in 
vivo. Our findings showed that the CD44high fraction of CSCs contained (1) an 
ESAhigh fraction which was the holoclone-forming population and had more epithelial 
characteristics (EPI-CSCs), and (2) an ESAlow fraction which was more migratory 
and formed more spheres (EMT-CSCs). These two subpopulations of CSCs were able 
to swift between each other, although the EPI-CSC fraction was highly bipotent 
(~100%), while only a proportion of the EMT-CSC fraction was bipotent ( 50%). 
We further investigated whether the CSCs phenotype and the switch between the two 
phenotypes (EPI-CSCs and EMT-SCSs) can be modulated by external signals from 
stem cell niches such as neighboring stroma (Paper II). OSCC-derived cell lines and 
primary cells were FACS sorted into a subpopulation enriched for CSCs (CD44high) 
and a subpopulation depleted in CSCs (CD44low), and the effect of carcinoma 
associated fibroblasts (CAFs), one of the major components of tumor stroma in 
carcinomas, on self-renewal and tumorigenic abilities of these subpopulations was 
investigated. The results demonstrated that CAFs were capable to enhance the self-
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renewal and tumorigenicity of OSCC cells, and that TGF-ȕ1 was the key regulator for 
this effect. Of most interest was the finding that CAFs induced clonogenic and 
tumorigenic abilities in the subpopulation of cancer cells depleted for CSCs, pointing 
to the need for all cell subpopulations to be targeted in cancers for successful therapy.    
Although FACS is used extensively for CSC sorting, the method might be prone to 
certain inconsistencies and a subjective way of gate setting, in addition to the fact that 
the antibody used for staining might modify the phenotype of cells when binding to 
them. Therefore we aimed to establish more functional and robust methods for 
isolation of CSCs (Paper III). The potential of a previously reported method for 
isolating normal epithelial stem cells using their differential adhesiveness to one of 
the main components of basement membrane, collagen IV, for CSCs enrichment was 
tested for OSCC-derived cells. Assessment of the biological properties of the 
subpopulations separated over different time according to their adhesiveness to 
collagen IV (RAC-10 min, MAC-30 min, and LAC-4 h) indicated that the rapid 
adherence to collagen IV can be used as a non-invasive and functional method to 
enrich for OSCC cells with increased colony and sphere forming ability, tumor 
formation ability and with high expression of stem cell-related markers (RAC). We 
also characterized these cells for their electrophysiological properties utilizing the 
technique of dielectrophoresis (Paper IV). The results showed that the subpopulation 
of RAC cells enriched for CSCs possessed differential electrophysiological properties 
when compared to the other subpopulations (MAC and LAC), and this was mainly 
due to their particular cell membrane morphology, very rich in cellular protrusions. In 
addition, this work suggested that CSCs in general might exhibit unique dielectrically 
features that can be putatively used in the future for their isolation, as a label-free and 
non-invasive method. 
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Abbreviations 
OSCC Oral squamouscell carcinoma 
CSCs 
TICs 
EMT 
MET 
CAFs 
FACS 
ESA 
NOD/SCID 
 
HNC 
Cancer stem-like cells 
Tumor-initiating cells 
Epithelial-to-mesenchymal transition 
Mesenchymal-to-epithelial transition 
Carcinoma associated fibroblasts 
Fluorescence-activated cell sorting 
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Head and neck cancers 
TA Transit amplifying 
EGFR Epidermal growth factor receptor 
COX-2 Cyclooxygenase-2 
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TGF-ȕ Transforming growth factor-ȕ 
ALDH1 
bFGF 
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BrdU 
3HTdR 
Aldehyde dehydrogenase 1 
Basic fibroblast growth factor 
Label-retaining cells  
Bromodeoxyuridine 
Tritiated thymidine  
SP Side population 
ABC 
HNSCC 
ATP binding cassette 
Head and neck squamous cell carcinoma 
 8
ALDH1A1 
NOD-scidIL2RȖnull 
BM 
DEP 
KSFM 
DMEM 
FBS 
BPE 
PBS 
RAC 
MAC 
LAC 
CM 
pHEMA 
H&E 
PFA 
PI 
PE 
TBST 
BSA 
PVDF 
4-MU 
StEM 
NOFs 
CAF-CM 
 
SEM 
Aldehyde dehydrogenase 1 family member A1  
NOD/SCID interleukin-2 receptor gamma chain null  
Basement membrane  
Dielectrophoresis 
Keratinocyte specific medium  
Dulbecco's Modified Eagle's Medium  
Fetal bovine serum  
Bovine pituitary extract  
Phosphate-buffered saline  
Rapid adherent cells  
Middle adherent cells  
Late adherent cells  
Conditioned medium  
Poly (2-hydroxyethyl methacrylate) 
Hematoxylin and eosin 
Paraformaldehyde  
Propidium iodide  
Phycoerythrin 
Tris-buffered saline with Tween 
Bovine serum albumin  
Polyvinylfluoride 
4-methylumbelliferone 
Standard error of the mean  
Normal oral fibroblasts 
Conditioned medium collected from Carcinoma 
associated fibroblasts 
Scanning electron microscopy 
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1. INTRODUCTION 
1.1 Oral squamous cell carcinoma 
1.1.1 Epidemiology 
Head and neck cancers (HNC) are defined as malignant tumors of the upper 
aerodigestive tract consisting of lip, oral cavity, nasal cavity, paranasal sinuses, 
pharynx and larynx [1, 2]. More than 650 000 new cases of HNC are diagnosed every 
year all over the world [3]. In Europe, there are approximately 143 000 new cases and 
more than 68 000 patients die due to this disease every year [3]. 
Oral squamous cell carcinoma (OSCC) is the most frequent type of tumor among 
HNC. It accounts for more than 90% of the cancer types occurring in the oral cavity 
[1, 4]. On a global scale, combined with oropharyngeal cancer, oral cancer ranks the 
tenth most common cancer, with the seventh most common cause of cancer induced 
mortality [1]. Over the past decade, OSCC has been shown to have a significant 
increased incidence, and a striking geographical variation with high incidence in 
South and Southeast Asian (e.g. China, India, Pakistan and Sri Lanka), as well as 
parts of Western and Eastern Europe (e.g. France, Hungary, Slovakia and Slovenia) 
(Figure 1) [5]. 
 
Figure 1. Countries with high incidence and mortality from oral cancer 
(Source: Warnakulasuriya, S.; 2009 [5]) 
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OSCC originates from the epithelial lining the oral cavity. Although the oral cavity is 
easily accessible, and oral cancer itself can be early detected, mortality from this 
disease remains high due to the late-stage diagnosis, therapy-resistant local and 
regional recurrence, and distant metastases [6-8]. Despite advances in surgical 
resection in combination with radiation and chemotherapy, OSCC patients still have 
poor life expectancy with a high mortality, and a 5-year survival rates ranging from 
50-55%, unchanged over the past several decades [9]. Furthermore, rates of 
secondary oral malignancies are also high with up to a third of patients suffering from 
tumor recurrence or secondary primary tumors [10].  
1.1.2 Malignant transformation of oral mucosa 
The development of cancer in the oral cavity is a highly complex multi-step process 
known as oral carcinogenesis (Figure 2) [11]. There are molecular studies proving 
that at least some of the cancers in the oral cavity progress from 
preneoplastic/precancerous lesions developing into carcinoma in situ, and then into 
invasive squamous cell carcinoma (Figure 2) [11, 12]. 
 
Figure 2. Oral carcinogenesis 
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Many OSCCs are thought to develop within a field of a disordered oral mucosa (the 
field cancerization theory) [11, 13, 14]. There are many terms used for the initial 
lesions, such as ‘pre-cancer’, ‘precursor lesions’, ‘pre-malignant’, ‘intra epithelial 
neoplasia’ and ‘potentially malignant disorders’, describing the same clinical 
appearance of a family of morphological alterations with increased potential for 
malignant transformation [15]. 
Potentially malignant epithelial lesions include oral leukoplakia, erythroplakia, palate 
lesion of reverse cigar smoking, oral lichen planus, oral submucous fibrosis, discoid 
lupus erythematosus, and hereditary disorders (such as congenital dyskeratosis and 
epidermolysis) [15]. Among them, oral leukoplakia and erythroplakia are the most 
recognized precursor lesions for malignant transformation in oral mucosa [16, 17]. It 
is desirable to find ways to predict malignant progression in an epithelial precursor 
lesion. The presence of epithelial dysplasia seems to be the most important indicator 
of a malignant progression in a precursor lesion [17, 18]. Nevertheless, the clinical or 
histological appearance alone does not predict very accurately the risk of malignant 
transformation [19]. In spite of tremendous progress in molecular oncology, none of 
the molecular markers alone, or in combination, is capable to predict malignant 
transformation in an individual patient [17]. 
1.1.3 Molecular pathogenesis of OSCC 
Many hallmarks of cancer, consisting of several essential capabilities acquired during 
the multistep development of human tumors, have been identified and characterized, 
providing a solid ground for understanding the biology of cancer. When they were 
first described, these hallmarks included sustained proliferative signalling, evading 
programmed cell death (apoptosis), limitless replicated potential, evasion of growth 
suppressors, sustained angiogenesis as well as activating the invasion and metastasis 
(Figure 3) [20, 21]. More recently, two more hallmarks of major importance for 
tumorigenesis were described, namely the reprogramming of cellular metabolism, 
evading immune destruction (Figure 3) [22]. In addition, two newly emerging 
enabling characteristics: genomic instability and mutations, as well as tumor-
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promoting consequences of inflammatory responses, were recognised a playing an 
important role in survival, proliferation, and dissemination of tumor cells (Figure 3) 
[22]. 
 
 
Figure 3: Hallmarks of cancer with emerging hallmarks and enabling characteristics 
(Source: Hanahan, D. and Weinberg, R. A.; 2011 [22]) 
Like other cancers, the multistep process underlying oral cancer evolves from the 
combined influences of individual’s genetic predisposition, and chronic exposure to 
environment carcinogens (such as tobacco, alcohol, oncogenic virus and 
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inflammation) which can lead to genetic, epigenetic, and metabolic changes (Figure 
4) [23]. Recent studies suggest that both precursor lesions and invasive OSCC share 
similar genetic abnormalities, loss of cellular control, and phenotypic characteristics 
that give to the transformed cells the ability to invade and metastasize [24, 25]. The 
multiple genetic alterations are able to activate mutations or amplify oncogenes and 
inactivate tumor suppressor genes, driving the progressive transformation of normal 
cells into highly malignant derivatives [20, 26]. In addition, it seems that the 
molecular targets relevant to cancer are most likely present in precursor lesions as 
well [24].  
Concerning the cell of origin of precursor lesions or OSCC, the normal basal stem 
cells have been considered the key target for alterations of their genotype, phenotype 
and physiology, and the starting point for malignant transformation in oral 
carcinogenesis [27]. In this view, the molecular mechanism underlying development 
of OSCC includes multistep genetic and epigenetic changes in basal stem cells, such 
as loss of cell cycle inhibitors p16, p14, and overexpression of epidermal growth 
factor receptor (EGFR) and cyclooxygenase-2 (COX-2). These changes would result 
in accumulating abnormalities in the relatively quiescent normal basal stem cells, 
most likely due to exposure of mucosa to carcinogens. Deletion of 9p21and 3p21 are 
related to the very early transformation from benign hyperplasia to dysplasia. 
Mutations in TP53 gene were also shown to precede transformation from 
premalignant stages to the invasive stage. Thus, losses of chromosomal material at 
9p, 3p, and 17p are considered as early changes of oral carcinogenesis, whereas 
losses at 13q and 8p are associated with late stages of carcinogenesis (Figure 4) [28]. 
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Figure 4: Classic histopathological and genetic tumor progression model of OSCC 
(Source: Richard, V., et al ; 2010 [28]) 
1.2. Cancer stem-like cells in OSCC 
1.2.1 Cancer stem-like cells 
Tumors are composed of a heterogeneous combination of various subpopulations of 
cells with different phenotypic characteristics and different proliferative and 
differentiation capabilities, and this is referred to as tumor heterogeneity [29].Two 
general models are thought to account for tumor heterogeneity: (1) the “stochastic” 
model or “clonal evolution”, and (2) the “cancer stem cell” (CSC) model [28, 30, 31]. 
The “stochastic” or “clonal evolution” model considers that most, if not all, cancer 
cells, although displaying different phenotypes, have proliferative and tumor 
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generating potential, despite of each single tumor cell having a low probability of 
exhibiting this potential (that can be assessed by clonogenicity or tumorigenicity 
assays). On the other hand, the “CSC” model postulates that tumor growth relies 
exclusively on only a distinct subset of cancer cells that show a consistent high 
proliferate potential, and that are ultimately responsible for tumor formation and 
growth, whereas most of the bulk tumor cells are depleted of this ability (Figure 5) 
[31].  
 
Figure 5: The two models of tumor evolution and heterogeneity 
The “CSC” model also postulates that this small group of cancer cells responsible for 
tumor maintenance, defined as “cancer stem-like cells” (CSCs) or “tumor initiating 
cells” (TICs), share striking similarities with normal stem cells, including the 
capacity for self-renewal, the ability to differentiate, active telomerase expression, 
activation of anti-apoptotic pathways, increased membrane transporter activity, and 
the ability to migrate and metastasize, and several studies have proven these as being 
indeed characteristics of CSCs [32]. CSCs are thought to maintain their low numbers 
by slow self-replication, and could undergo both symmetric and asymmetric 
divisions. In a state of tumor equilibrium, it is conceived that most of the CSCs are 
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able to generate another CSC and a transformed “progenitor-like” cell by asymmetric 
cell division. The progenitor-like cells have limited self-renewal ability but are highly 
proliferative, similar to a transit amplifying (TA) population in normal tissue, and 
give rise to partially differentiated bulk tumor cells through a combination of 
proliferation and abortive differentiation (Figure 6) [33]. 
 
Figure 6: Cancer stem-like cells (CSCs) hypothesis. 
Although the concept of CSCs remains a matter of controversy, prospective 
identification of cells that are able to self-renew and form new tumors can be 
performed in various ways, but the most common one is based on the differential 
expression of various cell-surface markers and fractionation of tumors into 
subpopulations of cells. The first evidence for the presence of CSCs came from acute 
myeloblastic leukemia, in which only a small subset of cancer cells was found to be 
clonogenic in culture [34]. CSCs could be then experimentally defined in human 
acute myeloid leukaemia (AML), where a rare subset of cells identified by its 
CD34+/CD38− phenotype were capable of initiating human AML after transplantation 
to immunocompromised mice [35]. Recently, more evidence suggests that CSCs exist 
in many different solid tumor types, including breast [36], colon [37], brain [38], lung 
[39], prostate [40], liver [41], and melanoma [42].  
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With respect to oral lesions, very early studies showed that only a subpopulation of 
tumor cells could form expanding tumor colonies, suggesting that human OSCC may 
contain some form of stem cells [43]. Later on, it has been shown that only a small 
subpopulation of the cells in OSCC corresponds to tumor-initiating cells [44], and 
that cells with self-renewal ability persist in OSCC cell lines even after long time in 
vitro propagation, and therefore appear to possess the essential defining properties of 
CSCs [45]. 
1.2.2 Stem cell niche 
Normal stem cells rely on a specialized microenvironment or niche for their survival 
and function [46]. Similar to normal stem cells, CSCs are considered to reside in a 
similar tumor microenvironment, termed “CSC niche”, which contains inflammatory 
cells, stromal cells such as fibroblasts, blood vessels, and extracellular matrix 
components (Figure 7) [47]. CSCs depend on their niche for support and maintenance 
of their stem characteristics. The niche allows CSCs to stay in an undifferentiated 
state by regulating the proliferative, self-renewal signaling, and the development of 
differentiated progenitor cells [48, 49].  
 
Figure 7. The CSC niche 
(Source: Krishnamurthy, S., and Nor, J. E.; 2011 [47]) 
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Furthermore, recent evidence have also demonstrated that the CSC niche play an 
important role in tumor metastasis by de-differentiating non-CSCs into CSCs,  
inducing epithelial-mesenchymal transition (EMT) and finally evolving in a pre-
metastatic niche at the new site, which contributes to the formation of metastasis 
(Figure 8) [46]. 
 
Figure 8. The CSC niche in tumor growth and metastasis 
(Source: Borovski, T., et al; 2011 [46]) 
Several studies indicated that fibroblasts, the predominant cell type in the stoma, play 
an important role on oral epithelial cell behavior and survival, including malignant 
tumor invasion [50, 51], and thus it has been theorized that fibroblasts would also 
play a major role for CSC maintenance, and be a part of the CSC niche  [52]. In 
OSCC, microenvironmental alterations that are related to fibroblast activation or 
conversion to an active phenotype appear to be involved in the malignant progression 
of oral epithelial cells [50, 51, 53]. Either through stimulation from cancer cells or by 
directly stimulation of the same exogenous agents that induce genetic alterations in 
the adjacent epithelial cells, fibroblasts could get activated or phenotypically change, 
and these activated/changed fibroblasts were generically called carcinoma associated 
fibroblasts (CAFs). The characterization and markers of CAFs are still controversial, 
but many studies indicated that CAFs share a similar morphology and phenotype with 
myofibroblasts [54, 55].  
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In the past decade, reports have shown that hypoxic niche contributes to tumor 
progression by activating adaptive transcriptional programs that promote cell 
survival, motility, and tumor angiogenesis [56]. Tumor cells were shown to 
accomplish the adaptation to microenvironment changes by expressing hypoxia 
inducible factors (HIFs), which may drive tumor growth through the generation or 
expansion of CSCs [57], and it has been shown that fluctuating hypoxia can indeed 
induce malignant progression and maintain CSC phenotype [57]. 
Endothelial cells present in the perivascular niche have been demonstrated to deliver 
critical cues for survival and self-renewal of stem cells in brain tumor [49]. Recently 
it has also been observed in OSCCs that the majority of the CSCs is localized in close 
proximity (within 100-ȝm radius) to blood vessels, and interacts with the components 
of the niche for their survival. Vascular endothelial cells that are surrounding and 
infiltrating tumors can secret factors to promote and enhance the survival and self-
renewal of CSCs [58].  
1.2.3 Epithelial-mesenchymal transition and mesenchymal-epithelial 
transition 
Epithelial-mesenchymal transition (EMT) has been defined in embryogenesis as the 
process in which polarized epithelial cells with regular cell-cell junctions and 
adhesion lose their cell-cell junctions, and convert from epithelial into individual 
mesenchymal or into elongated fibroblastic phenotypic cells [59]. Conversely, 
mesechymal cells can undergo reverse transition, termed mesenchymal to epithelial 
transitions (MET). EMT can also occur as a response to injuries, where epithelial 
cells nearby the injury site move towards the lesion to contribute to the healing 
process [60]. However, inappropriate reactivation of EMT seems to contribute to the 
development of a variety of human pathologies such as tissue fibrosis and cancer 
[61]. EMT has been observed in many epithelial cancers including OSCC [62]. 
During EMT, tumor cells acquire a more invasive phenotype that would allow them 
to migrate in extracellular microenvironments, and settle in the areas where new 
organ formation happens. Subsequently, the tumor cells that were of a more 
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mesenchymal phenotype while disseminating, are supposed to undergo the reverse 
transition, MET, at the secondary site and this would explain how most metastases 
preserve the pathology of their corresponding primary tumors [63]. 
Increasing evidence is gathering to demonstrate that acquisition of EMT 
characteristics by carcinoma cells plays a critical role in cancer progression and 
metastasis, which leads to tumor recurrence and poor clinical prognosis [64-67]. In 
carcinomas, dissemination of local carcinoma cells from primary tumor through the 
process of EMT is considered as the main mechaninsm for tumor cells to penetrate 
the fragmented basement membrane, intravasate into lymph or blood vessels, and 
then be passively transported by blood or lymph to distant organs. The solitary 
carcinoma cells at the secondary sites can then extravasate, and either remain solitary 
and dormant (micrometastasis) or form a new carcinoma (macrometastasis) through a 
reverse MET (Figure 9) [63]. 
 
Figure 9. EMT and MET in the emergence and progression of carcinoma. 
(Source: Thiery, JP, et al; 2002 [63]) 
As a caretaker of the epithelial phenotype, E-cadherin plays a vital role in the process 
of EMT and the reverse MET. Loss of E-cadherin can disrupt the mutual cell 
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connection and reduce the epithelial phenotype in epithelial cells through the 
regulation of a number of transcription factors such as Snail, Twist, and ZEB1 [68]. 
In addition to modulating cell-cell junctions, EMT can modulate other adhesion 
systems and induce actin cytoskeleton reorganization, leading to the mesenchymal 
phenotype and the scattering of carcinoma cells [59]. Controversial evidence shows, 
on the other hand, that up-regulation of E-cadherin in ovarian squamous cell 
carcinoma is highly related to malignant transformation and cancer growth although 
it induces epithelial features, being one of the few studies that suggests that MET 
plays a critical role in ovarian tumorigenesis [69].  
Recent reports have shown that EMT-phenotypic cells have stem cell-like features 
[70-72]. In human mammary carcinomas, CD44high/CD24low cells which have 
undergone EMT displayed many of the properties of CSCs, including forming 
mammospheres, soft agar colonies, and tumor formation ability, suggesting a direct 
link between the EMT and the gain of epithelial stem cell properties [73]. Various 
factors, including epidermal growth factor (EGF), fibroblast growth factor (FGF), 
platelet-derived growth factor (PDGF)-B, and PDGF-D as well as transforming 
growth factor-ȕ (TGF-ȕ), Notch-1and Wnt could induce EMT, while miR-200 family 
could inhibit EMT by regulating the expression of transcription repressors ZEB1 and 
ZEB2 [59]. TGF-ȕ pathway is one of the most common pathways of activating EMT 
in both neoplastic [74], and non-neoplastic tissues [75]. However, despite various 
studies that have investigated different aspects of EMT and carcinogenesis, this 
process is still not completely understood, and the newly suggested link to the 
maintenance of stem cell population in cancer made it more complicated [65]. 
1.2.4 Putative isolation and identification of CSCs 
As mentioned already, it has been recognized that many similar features exist 
between normal stem cells and CSCs, suggesting that the strategies employed to 
normal stem-cell may be usefully applied to the identification of CSCs in solid 
malignancies. Approaches commonly applied in isolation and identification of stem 
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cells are based on clonal sphere formation, expression of specific surface markers or 
dye exclusion, and label retention. 
Clonal sphere assay  
Clonal tumor spheres are non-adherent colonies of cells derived from single tumor 
cells when cultured in serum-free medium supplemented with growth factors, such as 
the basic fibroblast growth factor (bFGF) and EGF [76]. Studies on human neural 
tumors showed that after long-term cell culture, tumor spheres remain non-adherent, 
maintain the potential for proliferation and expand, whereas the remaining tumor bulk 
exhibits adherence, loss of proliferation, and subsequent differentiation, suggesting 
thus that neurospheres could identify the subpopulation with stemness properties of a 
marked ability for proliferation, self-renewal, and differentiation [76]. Corroborative 
studies have confirmed tumor sphere formation as an efficient assay in separating 
CSCs from a range of solid tumors [76-78]. The sphere-forming cell subpopulation 
derived from human liver cancer cell lines has been also reported having CSCs 
characteristics, including self-renewal ability, extensive proliferation, drug resistance 
and increased expression of liver CSCs-related markers including Oct3/4, OV6, 
EpCAM, CD133 and CD44 [77]. Tumor spheres in human sarcoma, termed 
sarcospheres, have been demonstrated to contain cells with stem-like properties with 
increased self-renewal capacity, over-expression of the stem cell-related genes such 
as Nanog, OCT3/4 SOX2 and DNA repair enzyme genes, MLH1 and MSH2 and 
strong drug resistance [79]. In HNSCC, using the non-adhesive culture system, tumor 
spheres, which formed in 5 or 7 days, have been proven to express putative stem cell 
markers and exhibited chemoradiotherapeutic resistance, in addition to tumor-
initiating and self-renewal abilities [80]. Taken together, these findings suggest that 
tumor sphere cells represent a relatively rare cell type that has self-renewal ability 
and increased tumorigenicity, thus they should be considered to represent a stem cell 
population. 
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Label retention assay 
Label retention assay is based on the theory that normal stem cells or CSCs either 
spend long periods without cycling (proliferative quiescence) or undergo an 
“immortal strand” DNA replication, and therefore would retain a labeled DNA for an 
extended long term [81]. The conventional explanation for label retention is that the 
label-retaining cells (LRCs) are slow-cycling and divide infrequently in undamaged, 
steady-state tissues [82]. Based on this explanation, label retention assay could 
exploit the slow-cycling property of stem cells, and therefore retain their labels, 
whereas TA progenitors are rapidly dividing, and dilute their labels [83]. Based on 
their ability to retain a nucleoside analog, label retention assay has been widely used 
for identification of stem cells in both normal and tumor tissues [84-86]. It has been 
reported, by using fluorescent membrane-labeling dyes such as PKH67/PKH26 label-
retaining cells, that cells with stem-like characteristics were enriched in the quiescent 
fraction of ovarian tumors [83]. In pancreatic adenocarcinoma, a label retention 
technique with lipophilic labeling dye DiI was used to identify a subpopulation of 
stem-like, slow cycling tumor cells which had increased invasive and tumorigenic 
potential [87]. By labeling with bromodeoxyuridine (BrdU), nasopharyngeal 
carcinoma stem cells could be detected both in vitro cell culture and in vivo 
subcutaneous inoculation in nude mice [88]. A subpopulation of basal epithelial cells 
which retains 3HTdR label for extended periods has been demonstrated in murine 
skin and oral mucosa [89]. So far, no reference have shown the distribution of LRCs 
in OSCC and whether CSCs in epithelial tumors are actually slowly cycling, but 
transplanted OSCC based on label-retaining may be useful to solve such questions 
[52]. 
However, recent studies reported that label retention may also be produced by 
unusual patterns of DNA segregation, as another explanation for label retention [52]. 
The studies using double labeling with Tritiated thymidine (3HTdR) and BrdU in 
normal intestinal mucosa suggested that stem cells segregate newly replicated DNA 
to the daughter cells expected to leave the stem cell compartment [90]. 
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Flow cytometry using Hoechst dye exclusion 
A distinct, minor cell population can be detected by dual-wavelength flow cytometry 
on the basis of the ability to efflux the fluorescent DNA-binding dye Hoechst 33342, 
referred to as side population (SP) as they fell to the ‘‘side” of the bulk of the 
positively stained cells in flow cytometry analysis plots [91]. The exclusion of 
Hoechst dye is mediated by the expression of ATP binding cassette (ABC) protein 
transporters, such as MDR1 and ABCG2 [91, 92]. SP cells were first identified in 
mouse bone marrow to highly enrich for cells expressing hematopoietic stem cell 
markers and with a long-term repopulating capacity [93]. After this original report, 
SP cells have also been characterized as stem cell populations in epidermal cells 
based on their high colony-forming efficiency, great proliferative potential and 
regenerative capacity of epidermal cells [94]. In normal tissues, it has been shown 
that SP cells possessed multi-potent differentiation capability and had increased 
expression of stem-like genes, thus, they were thought to have characteristics similar 
to stem cells [91]. 
More recent work demonstrated that SP cells were contributors to the maintenance of 
CSCs characteristics in many tumors [95, 96]. For example, in U373 glioma and 
MCF7 breast cancer cell lines, as well as LAPC-9 xenograft prostate tumor, SP cells 
were capable to generate non-SP cells in vivo, suggesting that SP cells have the 
capacity to differentiate. In addition, they were more tumorigenic than the 
corresponding non-SP cells indicating that they were also able to self-renew, 
fulfilling thus the two essential defining criteria of CSCs [95]. Similar observations 
have also been demonstrated in human lung cancer cell line NCI-H460[96] and 
gallbladder carcinoma cell line SGC-996 [97]. Concerning human oral cancer cells, 
SP cells isolated from SCC25 tongue cancer cell line were able to enrich for the 
CSCs as they showed great proliferation ability with high mRNA expression of stem 
cell markers including ABCG2, Oct-4 and EpCAM and drug resistance [98]. Taken 
together, these data indicate that SP cells do have similar properties to stem cells. 
However, it has to be noted that not all cell lines contain SP cells, hence this 
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population is not exclusively responsible for the prolonged in vitro lifespan of cell 
lines [91].  
Flow cytometry using cell surface markers 
Stem cells from normal adult tissues can be identified by expression of specific 
stemness protein markers and other stem-cell specific epitopes that are not expressed 
by somatic cells [99]. Similar to the normal stem cells, measurements of specific 
cluster of differentiation surface markers and stem cell-specific metabolic activities 
have been widely used for the characterization of CSCs [100]. The first evidence for 
identification of CSCs by using flow cytometry has been demonstrated in human 
AML by showing that isolated CSCs based on a specific phenotype were able to 
initiate leukaemia in transplanted immunodeficient mice [35]. Since the first study, 
this method has been applied to isolate CSCs by other researchers from various 
tumors, such as malignant glioma [101], osteosarcoma [102], breast cancer [103] and 
lung cancer [104]. Studies on both OSCC derived cell lines and OSCC primary cells 
have identified some markers which could be used for the isolation of stem cells from 
neoplastic oral mucosa. In OSCC-derived cell lines, consistently higher levels of 
expression of stem cell-related molecules such asȕ1 integrin, E-cadherin, ȕ-catenin, 
ESA and CD44 have been found in colonies with holoclone morphologies which 
were considered to be derived from stem cells [45].  
CD44 
CD44 protein, a cell-surface glycoprotein, involved in cell-cell interactions, cell 
adhesion and migration, displays a large array of cellular functions including 
hematopoiesis, lymphocyte activation, recirculation and homing. Numerous studies 
have showed that CD44 plays an important role in cell migration and tumor 
progression [105], and that its expression levels have prognostic value in certain 
malignancies [106-109]. CD44 was at first found to identify a population with stem 
cell properties in breast cancer, in which only a small subpopulation of cells marked 
with CD44+CD24-/low lineage- had the ability to form new tumor in vivo [36]. Further 
evidence showed that CD44 was a potential cell surface marker for HNSCC CSCs 
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[44]. By using the mouse xenograft model, it was demonstrated that a minor 
population of CD44+ cancer cells, but not the CD44− cancer cells, gave rise to new 
tumors, and the tumors that arose from purified CD44+ cells reproduced the original 
tumor heterogeneity and could be serially passaged [44]. In addition, CD44+ was 
shown to be constitutively expressed on the surface of permanent HNSCC cell lines, 
and it was indicated that it may drive the progression and metastasis of HNSCC 
[110]. 
Enzymatic activity detection of Aldehyde Dehydrogenase  
Aldehyde dehydrogenase 1 (ALDH1), a detoxifying enzyme, plays a role in early 
differentiation of stem cells through catalyzing the conversion of retinol to retinoic 
acid in normal and malignant stem cells [100, 111]. High ALDH activity has been 
shown in normal hematopoietic and central nervous system stem cells [112-115]. It 
has also been found that stem cell populations in multiple myeloma [115] and AML 
[116] had increased ALDH activity. In addition to be a marker for normal breast stem 
[111], ALDH1 has been found also active in stem cells of several tumors like human 
breast cancer [117], human pancreatic adenocarcinoma [118] and lung cancer [119]. 
Its activity might be essential for both longevity of stem cell and the resistance of 
CSCs against chemotherapy [100]. ALDH 1 family member A1 (ALDH1A1) has 
been suggested as a marker in HNSCC for distinguishing premalignant cells, and also 
a potential target for vaccination therapy for HNSCC patients [120]. Recently, 
ALDH1 expression has been reported to be a useful marker for sorting CSCs in 
HNSCC and ALDH1+/lineage- cells were shown to have increased self-renewal 
ability, tumorigenicity, and radioresistance [121].  
1.2.5 Mouse models in CSCs research 
Injection of tumor cells into immunodeficient mice is still considered to be the gold 
standard for measuring tumor initiating potential, and assessing the tumorigenicity of 
human tumor cells [40]. When xenografted, only a small fraction of the  human 
cancer cells form tumors, with one of the possible reasons being that they will be 
captured in an adverse mouse microenvironment or niche that would kill most of 
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them, the other possible explanation being that only a small, rare subset of tumor cells 
have the capacity to self-renew, differentiate, and propagate tumor growth, which are 
the defined features of CSCs [40]. 
Up to date, human CSCs have been studied upon xenotransplantation of neoplastic 
cells into mice with a compromised immune system (typically NOD/SCID mice) in a 
number of human malignancies, including leukemia [35], brain tumors [101],breast 
cancer [36], prostate cancer [40], ovarian cancer [122], and colon cancer [123]. Also 
for HNSCC, a cellular subpopulation expressing the surface marker CD44 was firstly 
isolated and identified as exhibiting stem cell-like characteristics and initiating 
tumors in an immunodeficient mouse model [44]. 
Recently, more highly immunocompromised NOD/SCID interleukin-2 receptor 
gamma chain null (NOD-scidIL2RȖnull) mice were generated and found to have a 
remarkably high engraftment level for human cells [124]. Using this new model, a  
study showed that approximately 25% of unselected melanoma cells formed tumors, 
while only rare 0.1 - 0.0001% of human cancer cells formed tumors when 
transplanted into NOD/SCID mice [125]. This study was more in the favor of the 
adverse mouse microenvironment as an explanation for the low xenotransplantation 
rate of human cells in mice rather than the presence of a rare subpopulation of CSCs.  
Thus, although mice models are very useful in generating knowledge on the biology 
of cancer cells, there are limitations for the interpretations of the xenotranslantation 
results in the light of human tumor pathogenesis, since these models can not 
accurately reflect the human microenvironment and immune response [126]. To 
minimize these pitfalls, some improved xenotransplantation models have been 
developed, such as genetically modified mouse models, or the mouse model with co-
implanted human stromal cells with CSCs, both of which are able to provide a more 
human-like or humanized growth environment [127]. 
Nevertheless, despite of its limitations, mouse models is still being regarded as one of 
the leading model systems in studying tumor pathogenesis since its use is 
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tremendously increasing our understanding of stem cell biology in cancer research 
[126]. 
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2. RATIONALE OF STUDY 
Appropriate treatment of OSCC remains one of the most difficult challenges in oral 
cancer. Mortality from this cancer remains high due to the therapy-resistant local and 
regional recurrence, and distant metastases. Despite all attempts, no significant 
progress has been achieved by combining traditional surgery and radiotherapy 
treatment with chemotherapy put any ref you like, but have one. Aaccumulating 
evidence demonstrate that solid malignancies, including OSCC, contain a small 
population of tumorigenic cells referred as CSCs or TICs [37, 45, 94, 128-130]. 
Typically, CSCs exhibit stem-like cell properties of self-renewing, tumor-sphere 
forming, differentiating into heterogeneous populations of cancer cells, and initiating 
new tumors when xenotransplanted into compromised mice [131], as well as 
initiating metastasis [132]. CSCs have been shown to display resistance to various 
therapeutical drugs and methods, leading to high recurrence and metastasis of 
carcinoma [133-136], therefore specific strategies aimed at targeting CSCs are 
essential for developing of an effective treatment for these tumors. In addition, the 
importance of EMT as one of the central mechanisms in invasion and metastasis, and 
the newly suggested link between EMT and the phenomenon of CSCs, point EMT as 
another yet important target for studies understanding carcinoma cell biology and 
treatments possibilities [128]. Effectors of EMT have been suggested as potential 
targets for development of improved tumor diagnosis, prognosis and therapy methods 
[137]. In breast cancer it has been shown that a CD44highCD24low subpopulation with 
CSC-phenotype has undergone EMT [73], but the link between EMT and CSC has 
not been studied in OSCC so far. The plasticity of CSCs and whether there is an 
established link between EMT and the phenomenon of CSCs in OSCC as well needed 
to be established. 
CSC behavior has been shown previously to be regulated not only by intracellular 
regulators such as transcription factors, but also by external signals from stem cell 
niches such as neighboring stroma [138]. Furthermore, a more recent study reported 
that exogenous TGF-ȕ, which has been shown to be an EMT inducer [139], played a 
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key role in CSCs maintenance also in breast cancer [73]. Again, the key regulators of 
CSCs in OSCC are not known; carcinoma associated fibroblasts (CAFs), one of the 
major components of tumor stroma in carcinomas, and their growth factor synthesis 
might affect self-renewal and tumorigenic abilities of oral malignant and 
premalignant-derived cells, but this needed to be proven. 
Nevertheless, the understanding of the biology of CSCs in OSCC is dependent on 
robust methods for their identification and isolation for further test. AlthoughFACS 
cell sorting for surface antigens that typify stem cells, is the most common approach 
to isolate the CSCs, it has several disadvantages. For instance, FACS requires high-
cost, high-speed sorters and high-quality antibodies [140]; the technique itself needs 
special skills and training to master. In addition, FACS profile is quite prone to 
certain external factors such as cell preparation (the cell type and concentration of the 
sorting cells), and/or a certain degree of subjectivity for gate setting in gradient 
staining. This brings forward a need to establish robust, less invasive methods for 
isolation of CSCs in OSCC, and functional approaches such as differential 
adhesiveness to a main component of basement membrane (BM), collagen IV, a 
previously reported method for isolating normal epithelial stem cell could be tested 
for this purpose [141, 142]. Another non-invasive, more functional technique, 
dielectrophoresis (DEP), based on an electrostatic phenomenon, has been recently 
shown to differentiate between stem cells and their progeny in neurogenesis [143]. 
Previous studies reported that DEP can separate and characterize different cell 
populations and measure electrophysiological properties in cancer, allowing it to be 
used as a characterization tool where differences exist in electrical properties between 
different cancer cell populations [144]. Up to now, there is no research performing 
DEP as a method to study the cells with stem cell properties in oral cancer and it will 
be promising if DEP can be used for future isolation of CSCs as a label-free and non-
invasive method. 
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3. AIMS OF THE STUDY 
To identify and biologically characterize the stem-like cells in human OSCC both in 
vitro and in vivo. 
Specific aims: 
1. To evaluate the plasticity of CSCs and whether there is a link between EMT and 
the phenomenon of CSCs in OSCC (Paper I). 
2. To determine the effects of CAFs on self-renewal and tumorigenic properties of 
oral malignant and premalignant-derived cells and determine the role of TGF-ȕ1 in 
stem cell maintenance, invasion and metastasis dissemination (Paper II). 
3. To investigate the rapid adherence to collagen IV as a method for enrichment for 
CSCs in OSCC and to further characterize the cell populations obtained using this 
method (Paper III). 
4. To investigate the differences in electrophysiological properties of the 
subpopulations of oral cancer cells with different stem-like cell properties isolated 
based on the different adhesiveness to collagen IV (Paper IV). 
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4. METHODOLOGICAL CONSIDERATIONS 
4.1 The choice of in vitro and in vivo studies 
The specific studies described in Papers I, II and III included both in vitro assay and 
in vivo xenotransplantation in order to investigate the biological characteristics and 
the behavior of cells with stem cell properties of OSCC. The study described in paper 
IV is a biophysiological study performed to determine the electrophysiological 
properties of cells with stem-like properties in OSCC derived cell lines. 
One of the essential biological feature attributed to CSCs or TICs is the tumorigenic 
potential [145]. The golden standard for tumorigenicity assay is still the in vivo 
transplantation mice system, in which human cancer cells are xenografted into 
immunocompromised mice (typically NOD/SCID mice) which could be assayed for 
tumor formation at various time points [81]. The transplantation mice system has 
been widely used for many CSCs researches due to its advantage of allowing 
studying the role of stem cells during cancer development and progression in 
dynamic physiological systems. Although CSCs from different tumor types seem to 
share certain markers for prospective identification, CSCs isolated from different 
tumor types could display marked behavioral and plasticity differences from one 
another. Properties which are useful for the identification and characterization of stem 
cells in a type of tumor might not be shared by the stem cells in another tumor, thus it 
is of major importance the choice of the specific assays to appropriately characterize 
the CSCs in a certain type of tumor [81]. Furthermore, although the subcutaneous 
mice model is widely used for xenotranplantation of various tumor types due to its 
simpler logistics, different mice models should be used in studying different types of 
tumors. In our studies, tongue xenotransplantation mice model was specifically 
chosen to characterize the tumorigenic potential of CSCs derived from OSCC. In this 
model, human tumor cells isolated form OSCC patients were injected into the tongue 
of the NOD/SCID mice. The advantage for this model was that it could mimic the in 
vivo microenvironment of the human oral cavity where OSCC are arising, and the 
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evaluation of the loco-regional spread of cells into the lymph nodes, which is one of 
the crucial step in oral cancer progression, and the only clinical parameter correlated 
with survival and prognosis in OSCC patients [146]. In addition, although not so 
straightforward and easy as the SC model, the tongue model allows also a relatively 
easy operation, examination, measurement and harvesting. 
In addition to the universally accepted in vivo assay for demonstrating the biological 
properties of stemness in tumors, in vitro assays and flow cytometry, have also been 
widely used. There are several in vitro assay systems that have been commonly 
performed for the analysis and characterization of CSCs, including colony formation 
assay and tumor sphere formation assay to test the self-renewal ability of CSCs; 
transwell migration/invasion assay and newly developed three-dimensional 
organotypic model to test the tumor cells invasive or migratory ability. Of 
importance, in addition to the fact that they can be performed with human cells only 
and thus being highly relevant for human pathobiology, the in vitro assays are also 
able to complement the other pitfalls of the in vivo assay, such as short experimental 
time, simple skills, and less cost. More important, cell lines derived from patients 
with tumors from different sites or from different stages of tumor progression offer 
the possibility to model the stepwise oral carcinogenesis and allow the study CSCs at 
different stages of transformation. 
Taken together, the combination of both in vitro and in vivo assays for 
characterization of CSCs appeared to be an accurate model for identification and 
analysis of biological properties of CSCs, and thus a combination of these assays was 
chosen for our experiments. 
4.2 Cell Culture 
4.2.1 Cell lines and culture medium (Papers I - IV)  
A panel of cell lines derived from oral malignancies and premalignancies were used 
in our papers. 
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- oral cancer cell lines: Uk1, Ca1, H357, 5PT, CaLH3.  
- oral dysplastic / premalignant cell lines: POE9n and DOK  
All of the oral cancer cell lines and DOK were routinely grown in FAD medium 
[147], which is 3:1 mixture of Dulbecco’s Modified Eagle’s Medium (DMEM, 
Sigma, St.Louis, USA) and Ham’s F12 (Sigma), supplemented with 10% Fetal 
Bovine Serum (FBS), 25 μg/mL Bovine Pituitary Extract (BPE), 0.4 μg/mL 
hydrocortisone (Sigma), 5 μg/mL insulin (Novo Nordisk, Bagsværd, Denmark), 20 
μg/mL transferrin (Sigma), 50 μg/mL L-ascorbic acid (Sigma), 20 μg/mL L-
glutamine. All cells were grown under standard cell culture conditions: a humidified 
incubator with 5% CO2 and 95% air at 37 °C. At 60-70% confluence, the cells were 
released using 0.25% trypsin-EDTA (Sigma). POE9n was grown in its growth 
medium, Keratinocyte Serum Free Medium (KSFM, Invitrogen, USA) supplemented 
with 10 ng/mL EGF and 25 μg/mL BPE (Invitrogen), and Dulbecco's Modified 
Eagle's Medium (DMEM) supplemented with 10% FBS and 5 μg/mL hydrocortisone. 
4.2.2 Generation of cells from primary human samples (Papers I, II and 
III) 
Fresh normal or OSCC tissue samples were collected following protocols after 
approval by the local Research Ethics Committee and after informed consent. Tissues 
were minced into approximately 1mm3 pieces, and then allowed to adhere to tissue 
culture dishes with KSFM (epithelial cells) or DMEM (fibroblasts) in incubator. 
After 1-3 weeks, the outgrowths from the explants were assessed morphologically, 
and the cells with either epithelial or fibroblast looking morphology were detached 
separately from the dishes by clonal rings, FACS was used to collect fibroblast-free 
epithelial populations based on the expression of epithelial-specific marker (ESA-
APC) (Biomeda), and to collect CAFs based on expression of PDGFRB (CD140b-
PE, R&D,USA). 
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4.2.3 Adhesion of cells to collagen IV (Papers III and VI) 
An early report has suggested that epidermal stem cells with high colony-forming 
ability could be separated by rapid adherence to basement membranes (BM), 
including collagen IV and fibronectin [148]. By adopting this method well 
characterized for isolating normal epithelial stem cells, we used rapid adherence to 
BM to enrich in CSCs in OSCC. Rapid adherence to collagen IV, or fibronectin-
coated dished, as well as to the simple plastic was used for optimization of this 
method in OSCC.  
Collagen IV coated dishes were prepared as following: collagen IV solution was 
made by 10μg/mL human collagen IV (BD Biosciences, USA) diluted with 10 mM 
acetic acid. Tissue culture dishes were then coated evenly with this solution at room 
temperature for 1 h, rinsed carefully with phosphate-buffered saline (PBS, Sigma) 
and sterilized by UV radiation overnight before using. Fibronectin was coated on 
dishes by adding 5mL FBS into culture dish in incubator overnight, as a method 
reported previously [45] and then washed once with PBS before using. Normal 
culture dish was used in our study as simple plastic. Single cell suspensions in 
medium were allowed to attach to coated-dishes or simple plastic in the incubator. 
Cells that attached within 10 min were trypsinized and collected as rapid adherent 
cells (RAC). The unattached cells within the first 10 min were then transferred to new 
coated-dishes or simple plastic and kept in incubator for the next 30 min. Cells that 
adhered within this period were collected as middle adherent cells (MAC), and again 
the floating cells remaining from this time period were allowed to attach in another 
new coated-dishes or simple plastic for the next 4 h and these attached cells were 
referred as late adherent cells (LAC). 
The ratio of primary OSCC cells from one patient (P1) adhering to collagen IV, 
fibronectin and simple plastic as RAC, MAC or LAC was calculated and differences 
were found for different types of coating (Figure 10). From RAC to LAC, the 
proportion of adherent cell population decreased in collagen IV-coated dish but 
increased in fibronectin-coated dish. For simple plastic, the cells were mostly 
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attached within 30 min. Thus, among these models, coating with collagen IV seemed 
to be the most valid method to indeed enrich in the rapid adherent cell population. 
 
Figure 10.Ratios of OSCC cells from patient 1 adhering to collagen IV, fibronectin and 
simple plastic over different time. 
The adhesion assay using rapid adhesiveness to collagen IV has been also chosen by 
many others previously, to enrich in stem cells in normal human [141], murine [21] 
and rabbit epithelium [142]. Therefore, we chose in our papers to sort different 
subpopulations based on adhesion to collagen IV over different time period, 
following the same procedure (Figure 11). Unfractionated cells that were not 
separated based on adhesive property were also used as control. 
Figure 11. Flow chart of isolation of OSCC cell subpopulations based on adhesion on collagen IV 
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4.2.4 Collection of fibroblast conditioned medium (CM) (Paper II) 
CAFs were grown in serum free DMEM medium overnight. CM was then collected 
and spun down to remove cellular debris. The supernatant was filtered through 0.45 
μm filter. This CM was frozen down or used fresh 1:1 with fresh culture medium to 
culture the cells. 
4.2.5 TGF-ȕ1 exposure protocol (Paper II) 
Previous reports showed that exogenous TGF-ȕ was one of the key niche factors that 
regulated the stem cell behavior in breast cancer [149] and glioma [150]. To 
investigate the effect of TGF-ȕ on self-renewal ability and tumorigenesis in oral 
premalignancy and malignancy, TGF-ȕ1 was added to oral dysplastic or cancer cell 
lines using the following protocol: 
Human TGF-ȕ1 (BD biosciences, USA) was activated by PBS containing 0.001% 
HCl. TGF-ȕ1 was then added (1ng/mL to 20ng/mL) into the serum free medium in 
different time periods (1h, 5h, 24h, 72h and 120 h) with the cells grown at clonal 
density.  
4.2.6 Treatment with 4-methylumbelliferone (Paper IV) 
The 4-methylumbelliferone (4-MU) stock solution (0.3 mM) was made by dissolving 
sodium salt 4-MU in distilled water. This stock solution was then diluted in cell 
culture medium and the cells were incubated in the presence of 4-MU for 48 hours. 
4.3 Cell Morphology 
4.3.1 Cell diameter measurement (Papers III and VI) 
Cell size, as previously reported, was related to cell phenotype, cell differentiation 
and proliferative potential in human keratinocytes and fibroblasts [151, 152].  
Furthermore, small cell size expressing stem cell-associated markers represented one 
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of the important stem cells properties and could enrich for putative stem cells in 
human corneal epithelium, while larger cells were more differentiated cells[153, 
154]. To evaluate the cell size of different CSC populations in our study, the 
diameters of subpopulations were measured under a microscope at a magnification of 
× 200. A minimum of 50 cells were measured in each independent experiment. 
4.3.2 Scanning Electron Microscopy (Papers III and IV) 
Collagen IV was coated on poly-lysine coverslips in 24-well plates (Nunc. Denmark) 
following the same procedure as described above for the culture dishes. A total of 
500 single isolated from cell lines were allowed to attach to poly-lysine and collagen 
IV-coated coverslips for 1.5 h at 37°. After fixation using 2% (v/v) glutaraldehyde in 
0.1 M phosphate buffer (pH = 7.2) at 4° for 2 h, samples were then subjected to 
graded ethanol dehydration and critical point dried, mounted on aluminium stubs, 
coated with evaporated carbon and viewed using a JeolJSM-7400 field emission-
scanning electron microscope. 
4.4 Stem cell assays 
Self-renew ability and tumorigenic potential are the hallmarks for CSCs. Thus, for a 
study aiming at characterizing CSCs should evaluate both these abilities. Clonogenic 
assay or colony formation assay was initially used to determine self-renewal capacity 
of CSCs in carcinomas, on the basis of the ability of a single cell to grow into a 
colony under adherent culture condition. More recently, a three-dimensional in vitro 
culture system, referred to as sphere forming assay, in which the cells grow in 
suspension/ non-adherent culture and form floating multicellular spheroids, which 
appears to mimic the in vivo condition was rather preferred to the colony formation 
assay [155]. Nevertheless, very recently it was pointed that the capacity to grown in 
suspension and form spheroids is more of an EMT ability than pure self-renewal trait, 
and thus the tumor initiation assay in animals models by transplantations of serially 
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diluted cell populations into mice with compromised immune system, typically 
NOD/SCID mice remained still the golden standard in studying CSCs [126]. 
4.4.1 Colony formation assay (Papers I, II, III and IV) 
Many studies on normal and cancer stem cells have linked stem cell properties with 
the morphology of colonies developed from single cells [45, 156, 157]. In this sense, 
colony formation (clonogenic) assay was designed as an in vitro stem cell assay to 
functionally investigate cell populations for their ability to self-renew. In our studies, 
colony formation assay was performed using the following two methods. 
1. Paper I- Tumor cells sorted by FACS were allowed to grow in culture before 
being resuspended, counted, and single cell cloned in 48-well plates by 
limiting dilution; or cells were seeded directly into 96-well plates by using the 
single cell plate sorting function of the FACS Aria sorter (BD biosciences). 
Wells were examined microscopically and those containing only a single clone 
were selected for analysis.  
2. Papers II and III – A total of 500 cells were seeded in 6-well plates within 3 
mL complete culture medium. After 7-10 days, wells were examined 
microscopically and stained with 0.5% crystal violet. Colonies were manually 
scored for analysis.  
4.4.2 Sphere formation assay (Papers I, II, and VI) 
Typically, stem cells form floating spherical structures when cultured in vitro under 
non-adherent conditions as spheres or in three-dimensional matrices relying on their 
property of anchorage independent growth [158]. In this sense, sphere-forming as an 
assay has been widely used in stem cell biology to evaluate both self-renewal and 
differentiation potentials. Sphere formation assay was initially generated from 
mammalian nervous system [159], and then used for the isolation and 
characterization of adult mammalian neural stem [160], prostate [161], and mammary 
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stem cells [161]. Increasingly, the application of sphere culture has been further used 
to isolate and maintain CSC subpopulations from various types of human tumors, 
such as brain [76], breast [162], pancreatic [163], ovarian cancers [122] and OSCC 
[164]. It is generally agreed that the tumor sphere-forming cells are able to 
proliferate, self-renew and possess in vivo tumorigenicity [77], which makes sphere 
formation as a functional assay for characterization of stem cell biology in tumors, 
and a surrogate for in vivo tumorigenesis assay. In our studies, sphere formation assay 
was used to determine in vitro self-renewal ability for various cell subpopulations 
isolated from OSCC. The protocol is described in detail below. 
Non-adherent culture plates were made by dissolving Poly (2-hydroxyethyl 
methacrylate) (pHEMA, Sigma) in 95% ethanol and coating the 48-well plates. The 
plates were then air dried overnight before using. 500 single cells were allowed to 
seed into the non-adherent plates within 500 μl FAD medium containing 1% 
methylcellulose for 7 days to 3 weeks. Wells were then microscopically accessed and 
viable spheres were manually scored for analysis.  
4.4.3 In vivo NOD/SCID mice model (Papers I, II, and III˅ 
Xenotransplation mice model could mirror the phenotypic heterogeneity of the 
primary tumor. CSC populations showed greater tumorigenicity as compared to other 
tumor cells when xenografted into immunocompromised mice [126]. When studying 
oral cancer studying animal models, it has been reported that tumorigenicity of oral 
cancer cells was greater in the orthotopic xenotransplantation model system rather 
than after subcutaneous injection in immunocompromised mice, which was more 
commonly used but could not reproduce primary tumor site microenvironment or 
local-regional/distant metastasis [165, 166]. To establish a good model to determine 
in vivo tumor-initiating ability of OSCC-derived cells, we have initially tested 
different types of xenotransplantation mice models which were tongue 
xenotransplatation (Figure 12), tail vein injection (Figure 13) and intracardiac 
injection using NOD/SCID mice. Tongue xenotransplatation model was the most 
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sensitive mice model for OSCC-CSCs study since it could reproduce both the 
primary tumors and the local regional metastasis-cervical lymph node metastasis at a 
low dilution (100) of CSCs. In addition, the ease for establishment and measurement 
of tumors and its ability to recapture the microenvironments of the primary oral 
cancer made it our choice. Using the tail vein injection model, no metastasis was 
found even injecting high dilution (10,000) of cells over 9 months. Intracardiac 
injection system was also excluded from our studies not only because of the difficult 
technique, but also for the high number of cells needed for metastasizing. Therefore, 
the orthotopic tongue xenotransplantation mice model was adopted in our studies to 
characterize the different OSCC cell subpopulations for their tumorigenetic and 
metastatic ability. NOD/SCID mice with the age of 6-8 weeks were used and kept in 
an isolation facility under pathogen-free conditions and a 12-hour day/night cycle. All 
animal procedures were approved by the Norwegian Animal Research Authority. The 
oral cancer cell lines or primary cells from OSCC patients with p53 mutations 
(evident by sequencing of exons 4-8 of TP53 gene) were selected for the injection. 
Cells suspended in 50ȝl of matrigel (BD Biosciences) were injected into the tongue 
of mice. Tumor formation and cervical lymph node metastasis were assessed at the 
onset of symptoms. Tumor volumes were determined by bidirectional measuring with 
callipers and calculated by the following formula: volume = (width)2 × length/2 [167].  
 
Figure 12. Tongue xenotransplantation model in NOD/SCID mice 
Of note, we also used the more immunocompromised NOD/SCID ILȖ2 deficient 
mice in order to be able to induce tumors by using DOK cell line (Paper II), a 
dysplastic cell line previously reported not to form tumors in nude mice, which 
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indeed did not form tumors when injected alone in any of the mice models we used. 
Nevertheless, when used in the NOD/SCID ILȖ2 mice and co-injected with CAFs 
DOK cells formed tumors, as described in paper II.  
 
Figure 13. Tail vein injection model in NOD/SCID mice 
4.5 Migration/Invasion assays (Papers I, II and III) 
As a hallmark of tumor metastasis, tumor cells should acquire a migratory and 
invasive phenotype in order to metastasize [168]. Some in vitro assays have been 
developed to investigate the migration and invasive ability of tumor cells. The most 
commonly used assay is the transwell migration/invasion assay system, which is 
performed by placing cells on top of plastic inserts with a cell permeable membrane 
and a chemo attractant underneath in multi-well tissue culture plate. The migration or 
invasion potential was determined by counting the cells which traversed the 
membrane and migrated or invaded towards the higher concentration of 
chemoattractant [169]. For invasion assay, a gel containing extracellular matrix 
proteins, such as matrigel, was used to mimic the in vivo matrices [169]. It has been 
shown that, by using this assay, a strong correlation between in vitro migratory or 
invasion ability of tumor cells and there in vivo behavior was found. Thus, in our 
papers, we adopted the following transwell migration/invasion assay to investigate 
the potential of migration or invasion of different OSCC cell subpopulations.  
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For transwell migration/invasion assay in our studies (Figure 14), cells were placed in 
medium with low concentration of FBS in the upper chamber of the transwell tissue 
culture inserts with 8-um pore membrane(Corning Incorporated, USA) in 24-well 
plates, with the medium containing higher concentration of FBS at the bottom of the 
well. After 18-24 h incubation, the non-migrated/non-invaded cells on the top of the 
membrane were removed by using a cotton wool bud. The migrated/invaded cells on 
the underside of the membrane were fixed in 4% paraformaldehyde (PFA), stained 
with Hoechst 33342 (Paper I) or crystal violet (Paper III) and counted. For invasion 
assay, the inserts were firstly coated with 250 μl of 6 μg/μl of matrigel (Invitrogen) 
mixed with KSFM and then performed as described above. 
 
Figure14. Transwell migration/invasion assay 
4.6 Three-dimensional organotypic model (Paper II) 
The conventional two-dimensional (2D) monolayer cell culture models lack complex 
intercellular and cell-matrix interactions at their real physiological state [170]. To 
circumvent the limitation of 2D culture models, organotypic in vitro models have 
been elaborated. In these model systems the tissue is reconstituted in the cell culture 
by seeding the cells of interest in a 3D structure under the specific spatial 
arrangement and architecture of the primary tissue. The 3D organotypic cell culture 
system has been considered as the most appropriate in vitro model for epithelium-
stroma interaction studies since they can restore in culture the 3D structure of 
environment and the in vivo microenvironment of the epithelial tissue is mirrored in 
these cultures [171]. For better understanding the biology of CSCs, it is essential for 
their optimal functionality to restore in culture their in vivo environment due to the 
close relationship between CSC populations and their niches including tumor stroma 
(such as fibroblasts). Thus, in our study on the role of stroma on CSC in OSCC we 
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used 3Dorganotypic culture models, as described in detail in the procedure below, 
where it was specifically used as an advanced in vitro model system for investigation 
of the role of epithelial-mesenchymal interactions on expression of stem-cell related 
markers.  
3D cultures were performed by seeding dysplastic and neoplastic oral keratinocytes 
on top of collagen I biomatrices by using a protocol well-established in our laboratory 
[172].Two types of organotypic cultures were prepared and used in our study (Figure 
15). In the first model (Figure 15a), namely organotypic monocultures, each different 
type of keratinocytes was grown on top of collagen simple collagen biomatrices 
without supplement of fibroblasts. In the second model (Fig. 15b), called the 
organotypic co-cultures, keratinocytes were seeded on the top of collagen biomatrices 
supplemented with primary fibroblasts. The organotypic cultures were grown in 
serum free culture medium [172] for 10 day and then lifted at air-liquid interface, 
harvested, formalin fixed and paraffin embedded or fresh-frozen [172]. 
Figure15. Organotypic cultures 
4.7 Flow cytometry 
Tumors are heterogeneous and contain a diversity of phenotypically different cell 
subpopulations. Flow cytometry is a powerful technique which could simultaneously 
analyze multiple parameters of individual cells, and thus sort out various 
subpopulations from heterogeneous tumors. Furthermore, as one kind of specialized 
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flow cytometry, FACS is able to separate the living cells for further assays based on 
the expression of cell surface markers [100]. Besides, flow cytometry could be used 
to analyze DNA content including cell cycle analysis, as well as some functional tests 
for cells. It also allows analyzing data using its correspondent software. Flow 
cytometry was used in our papers for both cell sorting (BD FACS Arian) and the 
analysis of cell cycle and ȕ1 integrin expression (BD Accuri C6).   
4.7.1 FACS sorting (Paper I and II) 
Cells were detached using either trypsin-EDTA (Sigma) or enzyme-free cell 
dissociation buffer (TrypLE™ Express, Invitrogen, USA) and then stained with 
antibodies (anti-CD44-PE, anti-ESA-APC antibody) at 1:100 dilution in PBS 
(Invitrogen, USA)  prior to FACS. To test for ALDH1 activity, cells were stained 
with Aldefluor reagent (Aldagen, Uk) according to the manufacturer’s instructions. 
The DAPI nuclear dye (1μg/mL, Sigma) (Papers I and II) or sytox blue (1μl/sample, 
Invitrogen) (Paper III) was used at to exclude dead cells.  
4.7.2 Cell cycle analysis (Papers I and III) 
Previous studies showed that CSCs in malignant human epithelium spend a longer 
time in G2 cell cycle phase which allowed for escapement of apoptosis by activating 
G2/M checkpoint proteins to provide more time for reparation of DNA damage [173]. 
Based on this, we performed the G2 cell cycle analysis by using flow cytometry in 
order to investigate whether there was a difference in the proportion of cells in the G2 
phase among different subpopulations of OSCC cells.  
Cells were fixed with 70% ice-cold ethanol and kept in 4 °C overnight. Before FACS 
analysis, the cells were washed with ice-cold PBS and then stained with propidium 
iodide (PI, 50 ȝg/mL in PBS) mixed with 125 ȝg/mL of RNAse A (Sigma) in dark at 
37 °C for 30 min. Then cells were washed with cold PBS, DNA contents were 
measured by using AccuriC6 Flow Cytometer (Accuri Cytometers, Inc., USA).  
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4.7.3 ȕ1 integrin expression (Paper III) 
Apart from being a stem-cell marker, ȕ1 integrin also functions as the major receptor 
for BM components such as collagen IV [148]. A relationship between the expression 
level of ȕ1 integrin on the cell surface and proliferative capacity has been found in an 
early study [148]. In addition, it has been reported that FACS sorting cells with high 
ß1 integrin expression can be used to isolate normal human epidermal stem cells from 
TA cells, since the cells highly expressing ȕ1 integrin showed the greatest colony 
formation efficiency [148]. Based on these previous findings, our study applied the 
flow cytometry analysis based on the following staining protocol for ȕ1 integrin in 
order to investigate the different OSCC subpopulations in term of their different 
expression level of ȕ1 integrin. 
Prior to flow cytometry analysis, cell were detached and stained with Phycoerythrin 
(PE)-conjugated mouse monoclonal anti-human ȕ1 integrin (R&D Systems) in 1:10 
dilution. Isotype mouse IgG1-PE (BD Bioscience) was used as control. ȕ1 integrin 
expression level was then measured by using AccuriC6 Flow Cytometer (Accuri 
Cytometers, Inc.,). 
4.8 Immunostaining 
4.8.1 Immunohistochemical staining (Papers I, II and III) 
Cells were grown on cover slips in 12 wells plates and then fixed in 4% PFA. The 
cover slips were attached to glass slides using loctite glue, and rinsed twice with 
1xTris-buffered saline with Tween (TBST). Heat induced epitope retrieval was done 
in 1x target retrieval solution (pH 6.0) in a pressure cooker or microwave treatment. 
Endogenous peroxidase activity was quenched with peroxidase block solution either 
before or after the addition of primary antibody. Ten percent solution of normal goat 
serum was made in a 3% Bovine Serum Albumin (BSA) in TBST to block the 
unspecific binding sites of the primary antibody. After discharging the solution of 
normal goat serum, the slides were incubated with the primary antibody at room 
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temperature in a humidified chamber for 60 min. Antibody diluent only was used as 
negative control. The slides was then rinsed and incubated for 30 min in room 
temperature with the secondary antibody conjugated with horseradish peroxidase 
labelled polymer (En vision kit, DAKO). The presence of antigen was visualized with 
DAB (3, 3’ diaminobenzidine, DAKO). The slides were then counterstained with 
haematoxylin (DAKO), dehydrated by immersing in increasing concentrations of 
alcohol followed by pure xyleneand mounted with an alcohol soluble mounting 
medium (Eukit, DAKO). 
In tongue xenotransplantation mice model, all tongue tumors and cervical lymph 
nodes were 5ȝm formalin-fixed, paraffin-embedded and stained for H&E or p53 
protein with a monoclonal specific antibody (DO-7 clone, titration 1: 50; DAKO) to 
identify the human cancer cells p53 mutated. 
4.8.2 Immunofluorescence (Paper II) 
For immunofluorescence, cells were fixed in 4% PFA and stained with various 
antibodies (1:100) in PBS with 0.25% BSA. Prior to imaging, cells were 
permeabilised with 0.1% Triton-X to allow the nuclear staining with DAPI (1 
ug/mL). 
4.9 Molecular assays 
4.9.1 RNA extraction and Quantitative-PCR (Papers I, II and III) 
Total RNA was extracted by using the RNeasy micro kit (Qiagen Inc., Valencia, CA, 
USA) (Papers I and III) or Cells Direct One-Step qRT-PCR kit (Invitrogen) (Paper II). 
Quantity and purity of the extracted RNA was checked using NanoDrop 
spectrophotometer (NanoDrop technologies, Inc., Wilmington, DE, USA). Total 
RAC reverse transcribed into cDNA using the Superscript III first strand synthesis 
supermix (Invitrogen) (Paper I and II) or High-Capacity cDNA Archive Kit system 
(Applied Biosystems, Foster City, CA, USA) kit (Paper II and III). QRT-PCR was 
then performed for the TaqMan assays.  
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4.9.2 Human stem cell RT² Profiler™ PCR Array (Paper III) 
The human stem cell RT² Profiler™ PCR Array (PAHS-405, SABiosciences, 
Frederick, MD, USA) containing primer pairs for 84 stem cell related genes was used 
to test the stem cell related genes. By using RT2 First Strand Kit (C-03, 
SABioscience,), total RNA was converted to first strand cDNA. PCR amplification 
was performed using the following cycling conditions: 95 °C for 10 min, (95 °C for 
15 s, and 60 °C for 1 min) × 40 cycles in ABI Prism Sequence Detector 7900 HT 
(Applied Biosystems, Foster City, USA).  
4.9.3 Western blot (Papers II and III) 
The protein concentrations were determined using Bio-Rad protein assay (Bio-Rad 
Laboratories, Hercules, CA, USA). Total cell protein was mixed with 10% SDS-
polyacrylamaide gel (Bio-Rad, USA) and resolved using a PVDF membrane 
(Amersham, USA) using standard procedures. Membranes were blocked by 
incubation with 5% non-fat dry milk in TBST for one hour at room temperature. 
Membranes were then incubated overnight at 4 °C degree with mouse monoclonal 
anti-BMI1 (1:1000, Millipore, USA) or anti-GAPDH (1:10 000, Abcam, Cambridge) 
as control. After washing in TBST, membranes were incubated with donkey anti-
mouse monoclonal antibody conjugated to horseradish peroxidase secondary 
antibody (1:1500, Jackson immunoresearch, USA) for one hour at room temperature. 
Super signal west Pico chemiluminescent substrate (Thermoscientific, USA) was 
used as enzyme substrate according to manufacturer`s recommendations. The 
membranes were visualized in SynGene scanner (VWR, USA).  
4.10 Dielectrophoresis (Paper IV) 
Dielectrophoresis (DEP), an electrostatic phenomenon, has been used to both 
characterise and separate different populations of cells for a variety of different 
purposes within biology and medicine, such as to study links between multidrug 
resistance and cancer [144]. In addition, DEP can also be applied for measurement of 
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electrophysiological properties in cancer, allowing it to be used as a characterisation 
tool where differences exist in electrical properties between different cancer cell 
populations. Furthermore, previous studies has demonstrated DEP as an approach to 
distinguish stem cells from their progeny [174] and to discriminate normal oral cells 
from pre-cancerous and neoplastic oral cell lines [6]. Up to now, there is no research 
performing DEP as a method to study the cells with stem cell properties in oral 
cancer. Thus, in our study, DEP was performed to determine the eletrophysiological 
properties of subpopulation which showed stemness properties in OSCC. The 
detailed procedure was described below. 
Cell suspensions were washed and re-suspended twice in isotonic medium consisting 
of 8.5% (w/v) sucrose plus 0.3% (w/v) dextrose buffer to remove traces of highly 
conductive culture medium [175]. Then, cells were re-suspended in low-conductivity 
medium (10 mS/m) at a concentration of 1.2×105 cells/mL. The DEP instruments 
(Figure 16) were set up and cells were added in to the the DEP Well chip (DEPTech, 
Ringmer, UK) (Figure 16c). The cells move (Figure 16a) within the DEP well over 
the course of each frequency and five frequencies per decade were measured between 
1 kHz and 20 MHz (Figure 16b). The system was controlled by a graphic user 
interface generated in MATLAB (The MathWorksInc, Nantick, MA). The change in 
light intensity across the well was measured (Figure 16b). By using “single shell 
model” approach [176], a “best fit” of the real part of the Clausius-Mossotti factor 
(Re[k(Ȧ)]) versus frequency was then found for the corresponding spectrum 
including cytoplasmic conductivity (S/m),effective membrane conductance (S/m2) 
and effective membrane capacitance (F/m2)  
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Figure 16. Instrument and example of cell movement in DEP 
4.11 Statistical analysis (Papers I-IV) 
Data were expressed as mean ± standard error of the mean (StEM) using. The 
samples were compared using a student’s t-test or non-parametric tests if the 
normality assumption was violated. Sometimes transformation of data in relative 
values was performed. Values of p < 0.05 were considered statistically significant. 
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5. MAIN RESULTS 
5.1 Isolation and characterization of OSCC CSCs based on FACS 
(Papers I and II) 
5.1.1. CD44high cells had high clonogenicity, tumorigenicity and metastatic 
ability, while CD44low cells showed low clonogenicity, tumorigenicity and 
metastatic ability (Papers I and II) 
Seeding OSCC cells at clonal density after FACS sorting showed that the cells of the 
CD44high subpopulation had significantly higher clonogenicity than the CD44lowcells. 
QPCR revealed that CD44high cells showed up-regulation for stem cell-related 
markers, such as CD44, CD133, Oct4A and Bmi1. In vivo tongue xenotransplantation 
revealed a much higher tumor burden and higher ability to infiltrate to the local 
lymph nodes for CD44high cells than for the CD44low cells, indicating that CD44low 
cells have lower ability to form tumors and local metastasis than the CD44high cells.  
5.1.2. CD44high fraction of CSCs contained an ESAhigh fraction which was 
the holoclone-forming population and had more epithelial characteristics 
(EPI-CSCs), and an ESAlow fraction which was more migratory and 
formed more spheres (EMT-CSCs), and these two subpopulations of CSCs 
were able to swift between each other in vitro (Paper I) 
When stained in addition with the epithelial marker ESA, two subpopulations of 
CD44high were found and sorted: CD44highESAlow and CD44highESAhigh. In adherent 
culture, CD44highESAlow cells had an EMT-CSC phenotype, since they displayed an 
elongated fibroblast-like appearance. In suspension culture, 10 times more spheres 
were found in CD44highESAlow cells compared to CD44highESAhigh cells. Time-lapse 
videos and transwell migration assays demonstrated that CD44highESAlow cells were 
more motile and migratory cells, a feature of cells undergoing EMT [177]. QPCR 
revealed that CD44highESAlow cells had up-regulated many EMT markers, including 
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vimentin, Twist, Snail and Axl, and down-regulated epithelial-specific genes, such as 
E-cadherin, Calgranulin B, involucrin and keratin 15.  
Single cell cloning revealed that almost all (~100%) of CD44highESAhigh clones but 
only a fraction (50%) of the CD44highESAlow clones could re-populate mixed 
populations, indicating that almost all CD44highESAhigh clones were bipotent, while 
approximately half of the CD44highESAlow clones were unipotent and only generated 
EMT cells. Further fractionation in CD44highESAlow/+ cells and CD44highESAlow/- cells 
showed that 44% of the CD44highESAlow/+clones were bipotent whereas none of the 
CD44highESAlow/- clones were bipotent. The CD44highESAlow/+cells were found to have 
considerably higher ALDH activity, considered more recently a hallmark of CSCs 
[178], than CD44highESAlow/- cells. FACS analysis based on ALDH activity revealed 
that CD44highESAlowALDH1+ cells contained more EMT-CSCs cells than 
CD44highESAlowALDH- cells, suggesting that the high ALDH1 activity marked the 
bipotent EMT-CSCs. 
5.1.3 CD44highESAhighcells (EPI-CSCs) had high tumorigenicity while 
CD44highESAlowcells (EMT-CSCs) had high metastasis ability in vivo 
(Paper I) 
To investigate these two CSC phenotypes, orthotopic injection into NOD/SCID mice 
was performed. Upon this, both EPI-CSCs CD44highESAhigh cells and EMT CSC 
CD44highESAlow cells were capable to form tumors in tongues after 26 days, whereas, 
only EMT-CSCs CD44highESAlow cells showed lymph node infiltration after 26 days 
and they showed lower tumor growth at late time points. The tumors were collected 
and further examined. The population of cells obtained by dissociation of mice 
tumors showed a mixed population by FACS, and the similarity of histology of the 
tumors in H&E staining indicated that these two CSC phenotypes were able to return 
into one heterogeneous cell population in vivo. 
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5.1.4 CAFs were capable to enhance the self-renewal and tumorigenicity of 
OSCC cells (Paper II) 
Apart from extracellular matrix molecules, various types of stromal cells (such as 
fibroblasts and myofibroblasts), soluble factors and signalling molecules create the 
complexity of the tumor microenvironment, which is highly involved in neoplastic 
transformation, tumor growth and invasion, as well as in the therapeutic resistance 
and tumor metastasis [179]. To elucidate the role of fibroblasts in maintaining the 
stem cell hierarchy in OSCC, co-culturing the oral dysplastic and cancer cell lines as 
well as primary OSCC-derived cells together with CAFs was used in Paper II. In 
vitro adhesion culture showed that significantly more colonies were formed in co-
cultured condition compared to seeding them alone in oral dysplastic cell lines and 
primary oral cancer-derived cells. Although not significant, the same effect was 
observed in oral cancer cell lines. In vivo tongue xenotransplantation revealed that 
CAFs enhanced markedly the tumorigenic ability when co-injected with oral 
dysplastic cells with CAFs into NOD/SCID IL2Ȗ deficient mice. When cancer cells 
were co-injected with CAFs in NOD/SCID mice, tumors size increased dramatically. 
After co-culture with CAFS, dysplastic and cancer cells showed increased mRNA 
level of stem cell factors Oct4A, BMI1 and CD44, although not statistically 
significnat in oral cancer cell lines. In addition, we found that both normal oral 
fibroblasts (NOFs) and CAFs increased the expression of CD44 when co-cultured 
with oral dysplastic dells and primary OSCC cells, but more prominent by CAFs. 
5.1.5 CAFs were able to turn the OSCC cell subpopulation depleted for 
CSCs (CD44low) in a clonogenic and tumorigenic population (Paper II) 
To investigate the influence of CAFs on non-stem cells in term of the stem cell 
abilities, CD44low cells derived from OSCC patients were used as a population 
depleted in CSCs, since they showed low-clonogenicity, low-tumorogenicity and 
low-metastasis abilities. When co-seeding oral dysplastic or cancer cells with 
fibroblasts, both NOFs and CAFs were able to induce more colonies and spheres of 
CD44low cells, but CAFs were more prominent. In vivo tongue xenotransplantation 
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showed a dramatic increase in tumor incidence, tumor size and lymph node 
metastasis when primary CD44low OSCC-derived cells were co-injected with CAFs. 
All together, these finding suggested that CAFs isolated from OSCC were more 
competent than normal fibroblasts in enhancing tumor growth by comingled OSCC 
cells, which was also described in breast cancer [180]. More importantly, paper II 
indicated that CAFs had a critical role in promoting carcinoma tumorigenesis 
supported by the fact that presence of CAFs could simulate cancer cells to proliferate 
and induce the potential of tumorigenicity of the non-stem population. This 
conclusion was also supported by the study on breast [181] and pancreatic tumors 
[182], in which a central role of CAFs in the promotion of tumor growth have been 
shown. 
5.1.6 TGF-ȕ1 was identified as being the key regulator for the CAF effect 
on inducing cancer stem-cell like properties in OSCC cells (Paper II) 
OSCC cells were treated with CM collected from CAFs (CAF-CM) or TGF-ȕ1 (that 
we found it secreted at higher levels by CAFs than NOFs). When CAF-CM was 
added, Ca1 and H357 cells formed more spheres which were slightly smaller in size 
and less compact, but expressed higher level of CD44 compared to non treated cells. 
Regarding to TGF-ȕ1 treatment, TGF-ȕ1-treated cells showed significantly increased 
number of colonies and spheres as well as stem cell related markers CD44, BMI1, 
Oct4 and Į6 integrin when compared with that of non-treated cells in most OSCC-
derived cell lines tested, but not in dysplastic cells. In addition, using 
immunohistochemical double staining for vimentin and CD44, the concomitant 
expression of EMT and stem-cell related markers was significantly raised after TGF-
ȕ1 treatment. 
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5.2 Isolation and characterization of OSCC CSCs based on 
collagen IV adhesion (Papers III and IV) 
5.2.1 The rapid adherence to collagen IV (RAC) enriched for OSCC cells 
with increased colony and sphere forming ability, tumor formation ability 
and with high expression of stem cell-related markers (Paper III) 
Recent evidence demonstrated that collagen IV played a major role in the 
maintenance of stemness in HNSCC-derived cells [183]. To investigate this in more 
detail and use this ability for isolation of CSCs in OSCC, we tested various 
subpopulations isolated based on their adhesion to collagen IV-coated dishes at 
different time points: rapid adherent cells (RAC-attached in first 10 min), middle 
adherent cells (MAC-attached in next 30 min) and late adherent cells (LAC-attached 
in the sequential 4 h). Using adherent culture and bright field microscopy, different 
cell phenotypes were found existing among RAC, MAC and LAC in OSCC-derived 
cells. Measurement of the cell diameter revealed a significant smaller size in RAC 
compared to MAC and LAC. Scanning electron microscopy (SEM) showed a regular 
spherical shape with folded and ruffled cell surface in RAC, and a flat appearance 
with smoother cell borders in MAC and LAC.  
Colony formation assay and sphere formation assay showed that RAC had 
significantly greater capability of colony formation and sphere formation than MAC 
and LAC. In line with these in vitro findings, in vivo tongue xenotransplantation 
demonstrated that RAC formed bigger tumors with faster tumor growth compared to 
MAC and LAC, although all these three subpopulations had to a certain degree 
tumorigenic ability. Moreover, lymph nodes metastasis was examined using 
immunohistochemistry staining for p53 showing that RAC had great potential of 
spread in the loco-regional lymph nodes than MAC and LAC. Overall, these findings 
indicated that RAC behaved more as stem-like cells with enhanced capability of self-
renewal and migrating compared to MAC and LAC. 
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P75 NTR was previously identified as a stem cell marker in normal human oral 
epithelium [184] and epithelium of esophagus [185], as well as esophageal squamous 
cell carcinomas [186]. A study on OSCC has reported P75 NTR as a marker for 
undifferentiated cancer cells and showed that it played a role in invasion and poor 
prognosis [187]. In Paper III, immunohistochemistry staining showed increased 
expression of P75 NTR in RAC compared to MAC and LAC. Human stem cell PCR 
Array further revealed a distinct mRNA profile of stem cell-related genes between 
RAC and LAC identified by unsupervised hierarchical cluster analysis of the PCR 
array data. Using SAM analysis, a panel of stem cell-related genes was found to be 
significantly up-regulated in RAC compared to LAC, such as CCND2, FGF2, 
PPARG, and ABCG2. Furthermore, significant up-regulation of FGF2, PPARG, 
CCDN2, TERT, and RPL13A and down-regulation in BMP1 were shown in RAC 
compared to LAC using specific TaqMan assays. 
Flow cytometry analysis for ß1 integrin, as a collagen IV receptor and a well-known 
stem cell marker, identified significantly higher level of ȕ1 integrin in RAC than 
MAC for both OSCC cell lines and primary OSCC cells. Flow cytometry analysis 
after staining for DNA content identified consistently higher proportion of cells in the 
G2 cell cycle phase in RAC compared with MAC and LAC in both the oral dysplastic 
cell line, OSCC cell lines and primary OSCC-derived cells. 
5.2.2 RAC cells, enriched for CSCs, possessed significantly higher effective 
membrane capacitance due to their particular cell membrane morphology, 
very rich in cellular protrusions (Paper IV) 
A gradually decrease of effective membrane capacitance (Ceff) was observed from 
RAC to MAC and LAC in oral cancer cell lines. RAC displayed the highest Ceff 
among the three subpopulations. Since Ceff level was known to be influenced by the 
morphology of the cellular membrane, we further investigated morphology-related 
aspects. In addition to having a significantly smaller diameter than MAC and LAC, 
RAC displayed a regular spherical appearance but with more folded cell membrane 
rich in both filopodia and lamellipodia membrane protrusions, whereas MAC and 
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LAC had a flat appearance with smoother cell membrane surfaces and less cellular 
protrusions on the surface. After treating all the three subpopulations with 4-MU, a 
known modulator of cellular protrusions, RAC changed markedly their membrane 
morphology by flattening of the cell surface, with loss of filopodia and decrease of 
Ceff, thus abrogating the difference existed among three subpopulations initially. This 
proved that the unique high Ceff in RAC was due to their particular cell membrane 
structure.  
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6. DISCUSSION 
6.1 CSCs in OSCC 
The CSCs model postulates a cellular hierarchy in tumors, in which only a subset of 
tumor cells have stem-like cell properties and ability to continually sustain tumor 
growth [188]. Although the concept of CSCs or TICs has often been controversial, 
increasing number of studies have reported the existence of CSCs in various solid 
tumors [188]. In OSCC, it has been described previously that as few as 5,000 
CD44high cells were able to form a tumor when xenotransplanted into 
immunocompromised mice, while higher number of CD44low cells failed to form 
tumors, indicating CD44high cells as the CSCs in OSCC. Consistently, our results 
presented in Paper II demonstrated that OSCC cells that highly expressed CD44 
possessed greater ability of self-renewal and tumorigenicity than that of CD44low 
cells, indicating that CD44high cells possessed almost exclusively the tumor initiating 
capacity. In Paper III, we applied a method based on rapid adhesiveness to collagen 
IV which has been reported previously for isolating normal human epithelial stem 
cell [141], to identify and enrich for OSCC CSCs. We found that the subpopulation 
that rapidly attached to collagen IV within 10min showed the highest self-renewal 
ability in vitro and tumorigenic potential in vivo, suggesting that this cell population 
(RAC) contains the tumor-initiating cells in OSCC. 
Phenotypically diverse CSCs are likely to exist in tumors [188]. Our results presented 
in Paper I identified two distinct phenotypes of OSCC-derived CSCs in addition to 
the non-CSC phenotype, using FACS sorting based on combination of CD44 
expression and ESA expression: (1) the holoclone-forming CD44highESAlow cells 
characterized as EPI-CSCs; (2) the sphere-forming CD44highESAlow cells 
characterized as EMT-CSCs, and (3) the paraclone-forming CD44low cells, again 
demonstrated as non-CSCs. Both of these two phenotypes of CSCs had tumorigenic 
capacity when xenotransplatated into the tongue of NOD\SCID mice.  
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Taken together, the findings presented here show, through different approaches, that 
OSCC seem to contain a subset of cells endowed with tumor initiating capacity that is 
phenotypically heterogeneous. 
6.2 Oral cancer stem cell niche/microenvironment 
It is known that the function of normal epithelial tissue stem cells is a result of the 
interaction with their surrounding cells and molecules that form a niche or 
microenvironment. Some previous evidence indicated that also in malignancy the 
CSCs seem to also be highly dependent on such a niche, including tissue-associated 
fibroblasts, to maintain their stem cell capacity [46, 189]. As one of the main stem 
cell niches in tumor, CAFs could sustain tumor growth and progression, in turn, their 
activated phenotype being induced and maintained by tumor cells [190]. A previous 
study on breast cancer have shown that co-injecting tumor cells with CAFs into mice 
was able to increase tumor take and decrease latency, whereas co-injecting them with 
normal fibroblasts induced opposite results [81]. Our results presented in paper II 
show that CAFs enhanced self-renewal ability in vitro and tumorigenic ability of 
OSCC cells in vivo and could stimulate the proliferation of OSCC cells, which in turn 
also could stimulate CAFs to proliferate. But in contrast to the study on breast cancer, 
our findings showed that NOFs could also increase the self-renewal ability in vitro, 
although not as prominent as CAFs. Nevertheless, our findings are in line with 
previous studies which suggested CAFs as one of the most prominent and influential 
cell type of the tumor microenvironment in various tumors, such as breast cancer, 
prostate and pancreatic carcinoma [190, 191].  
Previous studies reported that TGF-ȕ1was one of the main factors released by cancer 
cells and mediating CAFs activation [190]. Of interest, we found in our paper II, that 
CAFs acquire also the ability to synthesize TGF-ȕ1, as showed by the finding that 
they secreted significantly higher levels of TGF-ȕ1 than their normal counterparts. 
Our results show that TGF-ȕ1 simultaneously could increase self-renewal and 
migratory abilities in OSCC cells, as well as the expression of both stem cell and 
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epithelial-mesenchymal transition markers, suggesting that TGF-ȕ1 might be 
responsible for the effect of CAFs in increasing stemness in OSCC cells. This is in 
line with a very recent study on breast cancer stemness [73]. Taken together, these 
findings indicated that targeting CAFs and its mediator TGF-ȕ1 should be taken into 
consideration for more effective therapeutic strategies against oral cancer in the 
future. 
6.3 CSCs plasticity and EMT in OSCC 
A recent study suggested that CSCs are phenotypically and functionally 
heterogeneous and possess plasticity capacity [192]. The classic definition of cell 
plasticity, taken from stem cell biology, implies the ability of stem cells to 
differentiate into various cell lineages, and the plasticity of CSCs refers to their 
ability to reconstitute the cellular heterogeneity found in the original tumor [192, 
193]. In addition, the plasticity potential of malignant cells has been also described in 
epithelial tumors as a mechanism that allows the epithelial cells to transdifferentiate 
into mesenchymal cells through the process of EMT and reverse MET [194]. A very 
early report has demonstrated EMT as an intrinsic cell plasticity ability for epithelial 
tumor cells in culture, by showing their ability of changing the morphological 
features from epithelial-like cells to scattered fibroblast-like cells that were able to 
invade to BM [195]. EMT cancer cells were found to either sustain their 
mesenchymal trait under certain stimuli, or undergo reverse MET to return to 
epithelial-like cells when the stimuli was removed [196] . Furthermore, findings from 
breast cancer cells have established a link between CSCs and EMT by showing that 
the CD44highCD24low tumor initiating phenotype was also expressing EMT markers 
[73]. Corroborating with this study, our results presented in Paper I indicate that also 
CSCs in OSCC have a plasticity potential to bidirectional switch between the EMT 
and epithelial phenotypes, through both EMT and the reverse process of MET. This 
recently demonstrated phenotypic plasticity of CSCs builds more completely the 
early concept of migratory CSC enunciated by Brabletz based on their in vivo 
findings from colon cancer patients [65], suggesting that stationary CSCs (EPI-CSCs) 
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are still embed in the original epithelial tissue and remain proliferative although 
having differentiating capacities, while mobile CSCs (EMT-CSCs) disseminate from 
the original tumor and colonize at distant sites through the acquisition of EMT and 
then undergo MET to produce the growth of a metastatic tumor as the same epithelial 
trait as the parent tumor [65]. Of interest, we also showed in Paper I that for the CSCs 
having undergone EMT only the cells with ESAlow/+ALDH1+ expression pattern 
CSCs could reverse this process through MET to return to the epithelial phenotype. 
This may indicate that one population of CSCs that have undergone EMT is fixed in 
the mesenchymal lineage and is responsible for the dissemination from primary 
tumors, while the other population that is able to return to epithelial trait might be 
responsible for the tumor growth at the metastatic sites. 
6.4 Methods of isolation of OSCC CSCs 
The ideal method to identify CSCs should be efficient, specific, sensitive, simple and 
rapid [81]. Several assays exist, including FACS based on specific markers or 
Hoechst 33342 exclusion, sphere assay and label-retention assay. FACS is the most 
common method for selecting CSCs, and by its use several specific surface markers 
have been identified as stem cell markers in tumors. CD44 was firstly used as a 
candidate marker for CSCs in breast tumors [36], later on in HNSCC [45]. FACS is 
specific and sensitive; however, it has some technical limitations. For example, we 
could notice that the detection of the surface markers in samples was influenced by 
the culture condition, the procedure of obtaining the cell suspension, and the quality 
of the antibodies from the different producers. In addition, it required a large number 
of cells for sorting, but eventually a very limited number of CSCs could be available 
for further analysis [81]. Moreover, several logistic factors might influence the choice 
of FACS sorting for CSC isolation: (a) the instrument is expensive; (b) it requires to 
spend a substantial time on the instrument for sorting cells enough for subsequent 
studies; (c) quite subjective when defining the cell population (setting the gates); (d) 
no “golded markers” (well established, robust markers) for CSCs; (e) quite 
unpredictable reproducibility [80].  
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Using FACS for selection of SP on the basis of Hoechst 33342 exclusion has also 
been claimed to isolate stem cells in various tumors including human oral cancer 
[98]. However, SP could give rise to just a small and highly variable number (׽0.01 - 
5%) of CSCs, which were not enough for the further examination [95]. Its use is also 
questionable in its ability for valid CSCs identification since there were tumors or cell 
lines that did not present an identifiable SP, although CSCs should theoretically be 
present in every tumor and /or cell line [197].  
Recent studies have also shown that more functional methods, such as sphere 
formation via serum free medium with growth factor could enrich for a population 
with stem cell properties in OSCC, but a long time was required (׽ 2-3 weeks) to 
grow the sphere-like bodies [164]. In papers III and IV, we applied also a functional 
approach, using rapid adhesiveness to collagen IV to enrich in OSCC CSCs. 
Compared to the other techniques mentioned above, we found that in addition to 
being quite sensitive and robust, this was a simple, rapid, and non-invasive method 
for identification and characterization of CSCs, even though it still needed large 
number of cells to start with and ended up with a limited number of CSCs, especially 
in primary cells derived from OSCC patients. By using the collagen IV rapid 
adhesiveness to isolate CSCs, we further suggest in paper IV that another more 
functional, non-invasive method, DEP, may potentially be used for reliable and label-
free isolation of putative CSCs. This is a very novel approach for identification and 
isolation of CSCs, and thus it needs more investigation to determine and validate its 
use for identification of CSCs. Taken together, with all the efforts in this field, there 
is still no “best method” for isolation of CSCs, and continuous investigation for 
enrichment and characterization of CSCs is needed.     
6.5 Xenotransplantation mice model for CSCs in OSCC 
Although there is no animal model that could be perfectly applied to every type of 
human tumor [165], it is agreed that xenotransplantation tumor in immunodeficient 
animal models could mirror the phenotypic heterogeneity of the original tumor, and is 
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considered to be the most sensitive assay for identification of CSCs [126]. To date, a 
CSCs in many human malignancies have been identified using the 
xenotransplantation mice system that showed that the population of CSCs had greater 
tumorigenicity compared to other subtype of tumor cells [126]. By transplanting 
tumor cells into NOD/SCID mice, the presence of CSCs was at first demonstrated in 
AML, in which as few as 5000 CD44++CD38- cells could initiate leukemic 
proliferation, whereas 100 times as many CD44+CD38+cellswere not able to engraft 
[35]. After then, CSCs have been identified in many tumors, including breast [36], 
brain [38], prostate [198], colon [37] and ovarian [199] cancer. Ectopic subcutaneous 
transplantation system has been used as one of the common mice models for CSCs 
studies because of its easy way for establishing and measuring the tumors, as well as 
tumor reproducibility [165]. However, this system cannot accurately reflect primary 
tumor site microenvironment, which is maybe why a lot of therapeutic compounds 
showed disappointing outcomes when tested clinically despite of promising activity 
showed in subcutaneous xenotransplantation models [200]. In addition, detection of 
metastatic tumors in the subcutaneous implantation model is hardly detected since its 
non-organ specific tumor environment. Therefore, orthotopic animal models have 
been more and more used instead of ectopic animal models as it provides a more 
natural host microenvironment that can reproduce tumor-host interactions which are 
lacking  when ectopic transplanting the tumor cells subcutaneously [165, 201]. 
Xenotransplantation of various subpopulations of OSCC cells into the tongue of 
NOD/SCID mouse was used as an orthotropic model in our current studies and 
strikingly, it showed that as few as 100 RAC populations (CSCs) from human 
primary OSCC could initiate tumors, compared to MAC and LAC (non-CSCs) that 
initiated tumors at higher numbers. Furthermore, cervical lymph node metastasis 
could be detected in most of the mice that were injected with different dilutions of 
human CSC OSCC cells (100; 1,000; 5,000; 10,000). These findings are in line with 
previous studies where by using an orthotopic tongue xenotransplantation mouse 
model, the cervical lymphatic metastasis potential could be assessed in mice [165, 
202]. Nevertheless, with all its advantages, the tongue xenotransplantation brings up 
some concerns, as we also observed. The tongue of the mice is very tiny to inject 
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voluminous tumor samples, and the mice were easy to lose due to post injection  
increase in volume of the tongue, especially when injections were made near the base 
of the tongue, this being able to induce difficulty in breathing for mice and ultimately 
asphyxia. Another very specific limitation for inducing tongue tumors in mice is that 
the increased volume of the tongue due to the growing tumors might lead to 
difficulties in eating, the mice needing to be sacrificed before the metastases were 
detected due to their loss in appetite, impairment in chewing and swallowing and 
ultimately loss in weight. Nevertheless, tongue xenotransplantation mice model still 
serves as a great in vivo experimental model, not only as a highly sensitive assay for 
CSCs, but also for tumorigenicity and metastasis in OSCC in general. 
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7. CONCLUSIONS 
I. By using FACS analysis based on higher expression of CD44 combined with ESA 
expression, two distinct CSCs subpopulations in OSCC could be identified. They 
were the CD44highESAhigh subpopulation, the EPI-CSCs which was more potent in 
local tumour initiation and growth, and the CD44highESAlow subpopulation, the EMT 
CSCs which had more potential in metastasising. These two populations seem to co-
exist in OSCC by switching between them through EMT and the reverse process of 
MET. 
II. CAFs were capable to increase the self-renewal properties of OSCC cells by 
inducing stem-like properties in the non-stem subpopulation of oral carcinoma cells, 
and TGF-ȕ1 seemed to be the main mediator of this effect. 
III. Rapid adhesion to collagen IV could be used as a sensitive enough and robust 
method to enrich for a population containing putative CSCs/TICs in OSCC. 
IV. CSCs exhibit unique dielectrically features (high Ceff) that can be putatively used 
for their isolation, as a label-free and non-invasive method. 
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8. FUTURE PERSPECTIVES 
I. To investigate the dynamic/kinetics of the EPI-CSCs/EMT-CSCs switch and how 
the equilibrium between various subpopulations of cells is maintained at the 
molecular level. 
II. To investigate the dynamic/kinetics of the non-CSC/CSC switch and how the 
equilibrium between various subpopulations of cells is maintained at the molecular 
level. 
III. To explore the role of exogenous factors such as TGF-ȕ1 in the dynamic switch 
and phenotypic equilibrium.  
IV. To explore the role of Axl in the dynamic switch and equilibrium of EPI-
CSC/EMT-CSC. 
V. Modeling and development of intracardiac mouse model system using newly 
developed NOD-scidIL2RȖnullmice to model and compare the differential response 
towards niches described above in terms of tumorigenesis and metastasis in OSCC.  
VI. Further developing a method for OSCC CSCs sorting based on their unique DEP 
characteristics. 
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